Vienna

• FI-3, Fidelia Recruiting
  2024-518243-38-00 5 2022-04-20 Fecal incontinence in female and male patients
• Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants Wi … Recruiting
  2023-504599-10-00 4 2022-03-29 Chronic lymphocytic leukemia recurrent
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• InvestiGating the rOle of Growth Hormone in hepatic lipid metabolism in humans Recruiting
  2024-518214-11-01 4 2022-01-01 acromegaly
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 5 2021-11-05 Histologically proven high-risk medulloblastoma, with any of the curre
• LANDI-POAF study Recruiting
  2024-518950-17-00 5 2021-10-18 Beta-blocker intake
• Examination of medication-induced skin inflammation models and their use in the study of antibiotic concentration in inflamed, infected, and … Recruiting
  2024-518477-34-00 3 2021-10-13 Skin inflammation
• EXTENSION STUDY FOR PATIENTS WHO HAVE COMPLETED A PRIOR GLAXOSMITHKLINE/TESARO-SPONSORED NIRAPARIB STUDY AND ARE JUDGED BY THE INVESTIGATOR … Recruiting
  2023-506618-29-00 4 2021-09-22 Advanced ovarian, breast, or prostate cancer
• Felzartamab in late ABMR Recruiting
  2024-511764-86-00 4 2021-09-07 late antibody mediated renal transplant rejection
• VitDM3BH Study Recruiting
  2024-518897-15-00 4 2021-07-07 Vitamin D insufficiency undergoing tooth extraction
• The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli … Recruiting
  2024-512953-26-00 5 2021-07-06 intermediate-stage hepatocellular carcinoma
• Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma … Recruiting
  2023-508922-83-00 10 2021-03-17 Advanced Non-Small Cell Lung Cancer
• Open-label Phase 2 of tabelecleucel in Subjects with Epstein Barr Virus associated Diseases (EBVision) Recruiting
  2024-516623-14-00 4 2021-03-17 EBV+ primary imunodeficiency lymphoproliferative disease (LPD)
• Beta-blockade in cardiac arrest Recruiting
  2024-518949-14-00 4 2020-11-30 cardiac arrest, ventricular fibrillation
• Treatment of neovascular AMD: Artificial intelligence in real-world setting Recruiting
  2024-518482-99-01 6 2020-11-16 neovasclar AMD
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyel … Recruiting
  2023-507885-21-00 4 2020-08-18 Chronic Inflammatory Demyelinating Polyneuropathy
• Pan tumor Roll Over Study Recruiting
  2023-506914-32-00 4 2020-05-05 Pan tumor
• Epiflux Recruiting
  2024-515540-23-00 4 2020-04-15 Focal epilepsy
• Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting
  2023-508956-20-00 5 2020-03-12 Hidradenitis suppurativa
• A PROSPECTIVE, OPEN-LABEL, MULTICENTRE PHASE-II-TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ZANUBRUTINIB (BGB-3111), A BTK INHIBI-TOR, PLUS … Recruiting
  2023-504653-12-00 4 2020-02-10 Patients with previously untreated Richter Transformation or patients
• International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica … Recruiting
  2022-501454-11-00 5 2020-02-05 standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
• Pharmacokinetics of antibiotics in bile fluid of patients with external biliary drainage Recruiting
  2024-517165-17-00 3 2020-02-03 Cholangitis
• Investigation of neurobiological mechanisms of antidepressant action of ketamine using neuroimaging Recruiting
  2024-519234-23-00 3 2020-01-17 Healthy volunteers - no medical condition

Showing 385–408 of 828 trials